Colleen Reitan

Colleen Reitan

Director/Board Member at ALNYLAM PHARMACEUTICALS, INC.

Net worth: 837 594 $ as of 31/05/2026

66 year
Technology Services
Health Technology
Health Services

Profile

Ms. Colleen F.
Reitan
is an Independent Director at Myriad Genetics, Inc. and an Independent Director at Alnylam Pharmaceuticals, Inc. She is on the Board of Directors at Myriad Genetics, Inc., Cricket Health, Inc. and Alnylam Pharmaceuticals, Inc. Ms. Reitan was previously employed as a President & Chief Operating Officer by BCBSM, Inc. She also served on the board at Health Care Service Corp., Availity LLC, MEDecision, Inc. and Prime Therapeutics LLC.
She received her undergraduate degree from Minnesota State University-Mankato and a graduate degree from the University of Minnesota.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 152,030 ( 0.16% ) 603 559 $ 31/05/2026
20/05/2026 775 ( 0% ) 234 035 $ 31/05/2026

Colleen Reitan active positions

CompaniesPositionStart
ALNYLAM PHARMACEUTICALS, INC. Director/Board Member 01/06/2018
MYRIAD GENETICS, INC. Director/Board Member 25/09/2019
Director/Board Member 26/08/2019

Former positions of Colleen Reitan

CompaniesPositionEnd
Chief Operating Officer 01/01/2015
President 01/01/2008
Director/Board Member -
Director/Board Member -
Director/Board Member -
See the detail of Colleen Reitan's experience

Training of Colleen Reitan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Finance

Technology Services

Health Technology

Health Services

Health Services

Consumer Services

Consumer Services

Technology Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Colleen Reitan
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!